Early Life Abuse Moderates the Effects of Intranasal Oxytocin on Symptoms of Premenstrual Dysphoric Disorder: Preliminary Evidence From a Placebo-Controlled Trial
Background: Although intranasal oxytocin (OXT) has been proposed to be a promising treatment for some psychiatric disorders, little research has addressed individual difference factors that may predict response to OXT. One such factor is early life abuse (ELA), which has widespread influences on soc...
Main Authors: | Erin C. Walsh, Tory A. Eisenlohr-Moul, Cort A. Pedersen, David R. Rubinow, Susan S. Girdler, Gabriel S. Dichter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2018.00547/full |
Similar Items
-
Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder
by: Pai-Cheng Lin, et al.
Published: (2021-06-01) -
Prevalence, pattern and predictors of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) among college girls
by: Anitha Durairaj, et al.
Published: (2019-01-01) -
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives
by: Rapkin AJ, et al.
Published: (2019-09-01) -
Premenstrual Symptoms and Work: Exploring Female Staff Experiences and Recommendations for Workplaces
by: Claire Hardy, et al.
Published: (2021-03-01) -
Women’s experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation
by: Elizabeth Osborn, et al.
Published: (2020-10-01)